C
hemokine receptors belong to a subset within the superfamily of seven-transmembrane domain, G protein-coupled receptors that generally function to direct the complex migratory or trafficking patterns of leukocytes (1, 2) . Most chemokines are small secreted proteins that are grouped according to the highly conserved position of cysteine residues within their N-terminal region into C, CC, CXC, and CX 3 C families (3) (4) (5) . Although chemokine receptors often exhibit multiple ligand specificities, this promiscuity is generally limited to the binding of chemokines within the same family (2) . Because of this, chemokine receptors are classified based on the family of chemokines that they bind. Greater sequence homology also exists within each of the CC and CXC families of chemokine receptors than between the two families. Moreover, the CC chemokine receptors CCR1-CCR5, CCR8, CCR9/10, and CX 3 CR1 are closely linked on chromosome 3p21 (6 -10) .
Members of the chemokine receptor family also serve as coreceptors, in conjunction with the CD4 molecule, for entry of HIV and SIV into target cells (11) (12) (13) (14) (15) (16) . CCR5 is the major coreceptor for R5 strains (previously referred as M-tropic) of HIV-1 and most SIV strains, while CXCR4 allows entry of X4 strains (previously referred as T-tropic) of HIV-1 (11) (12) (13) (14) (15) (16) . Additionally, CCR2, CCR3, CCR8 and CX3CR1 have been reported to be used by some of the HIV/SIV isolates, albeit at lower efficiencies (17) (18) (19) . Several chemokine-receptor-like orphan receptors have also been shown to function as coreceptors for HIV and SIV strains (20 -23) . One of these seven-transmembrane domain orphan receptors, Bonzo (also named STRL33 or TYMSTR), was identified as a principal coreceptor for several strains of SIV (including SIVagm and SIVsm family viruses) as well as some HIV-2 and HIV-1 strains (20 -23) . Bonzo is a putative chemokine receptor based on sequence homology with other chemokine receptor family members. However, its biologic function is not understood, and no natural ligand has yet been identified among the known human chemokines (21) (T. Schall, unpublished observation). Expression of Bonzo mRNA is restricted to lymphoid tissues, PBMC, and placenta (20 -23) . Interestingly, the Bonzo gene maps to human chromosome 3 close to the region where genes encoding CC family chemokine receptors are clustered (21) . Little is known about the cell subset-specific expression and regulation of Bonzo. The in vivo distribution of Bonzo-expressing cells and the modulation of this expression may be important in determining the role of Bonzo in SIV and HIV pathogenesis. To address this issue we have used a mAb specific for Bonzo to demonstrate that expression of this receptor is highly restricted to the memory subset of resting human T cells. We further show that, similar to CCR5, Bonzo expression is up-regulated by the cytokines IL-2 and IL-15. However, in contrast to CCR5, upon PMA treatment or TCR stimulation Bonzo was not down-modulated. A similar expression pattern was observed on mouse CD4
ϩ T cells of mice in which a green fluorescent protein (GFP) 4 gene was knocked into the endogenous Bonzo locus.
Materials and Methods

Generation of mAb against Bonzo
An mAb against Bonzo/STRL33 was raised at R&D Systems (Minneapolis, MN) by immunizing BALB/c mice with a syngeneic mouse myeloma (NSO) transfected with full-length human Bonzo/STRL-33 with a polyhistidine fused to the C-terminal end of the receptor sequence. The polyhis serves as an epitope tag that can be used to identify (via intracellular staining in FACS or via Western blot) transfected clones that appear to be expressing high levels of the gene of interest. An immunization protocol (24) for soluble protein was adapted for use with whole cells as the immunogen. The priming immunization was performed by mixing the cell suspension in PBS with an equal volume of emulsified MPL/TDM adjuvant (Ribi); subsequent boosts used cells in PBS alone. Following immunization, lymph node cells were used for polyethylene glycol-mediated fusion following conventional protocols. After 7 days of culture, supernatants were screened for Abs that could bind to paraformaldehyde-fixed NSO/STRL-33/polyHis cells used for immunization. Cultures that were positive in this primary screen were then tested for binding to NSO cells that had been transfected with an irrelevant gene (GDF-9) also expressed as a polyhis construct. One clone was chosen and subcloned based on strong binding of its supernatant to the unfixed relevant transfectants. This hybridoma secretes an IgG2b mAb that was purified and used in subsequent experiments. This Ab is designated MAB699.
Preparation of human PBMC and resting T cells
PBMC were separated from buffy coats of healthy donors (New York Blood Bank, New York, NY) through Ficoll-Hypaque (Pharmacia, Uppsala, Sweden). Purification of T cells was performed as previously described (25) . Briefly, monocytes were first removed from PBMC by plastic adherence for 2 h at 37°C. Nonadherent cells were incubated with anti-CD4 or anti-CD8 conjugated with Dynabeads (Dynal, Oslo, Norway) at a 1:4 target/bead ratio. The bead-bound cells were recovered using a magnet (Dynal) washed at least four times to remove unbound cells. The CD4 ϩ or CD8 ϩ cells were detached from the beads using Detachabead according to the manufacturer's instructions (Dynal). These cells were then incubated with anti-HLA-DR Ab followed by Dynabeads conjugated with goat antimouse IgG for magnetic removal of preactivated T cells and contaminating dendritic cells or macrophages.
Media, reagents, and T cell cultures
The culture medium used in all experiments was RPMI (Life Technologies, Grand Island, NY) supplemented with 10% FCS (HyClone, Logan, UT), penicillin (50 U/ml; Life Technologies), streptomycin (50 g/ml), sodium pyruvate (1 mM; Life Technologies), and glutamine (2 mM; Life Technologies). T cell lines were prepared by activation of purified resting T cells with allogeneic PBMC and were treated with 50 g/ml mitomycin C (Sigma) for 30 min at 37°C and 5 g/ml PHA (Sigma). Cells were split 3 days postactivation, expanded, and maintained in culture medium supplemented with 200 U/ml recombinant IL-2 (Chiron). T cell lines were maintained by restimulating the cells every 2 wk with PHA and mitomycin C-treated allogeneic PBMCs. Culture of T cells with cytokines has been previously described (26, 27) . Cytokines IFN-␥, IL-4, IL-7, IL-12, and IL-15 and chemokines RANTES, macrophage inflammatory protein-1␣ (MIP-1␣), MIP-1␤, and stromal cell-derived factor 1␣ (SDF-1␣) were all obtained from R&D Systems.
Ab staining and FACS analyses
Cells were incubated with the relevant Ab on ice for 30 min in PBS buffer with 2% FCS and 0.1% sodium azide. For staining of Bonzo, cells were incubated with anti-Bonzo mAb at 3 g/ml; after two washes, cells were incubated with goat anti-mouse IgG conjugated to PE or tricolor (TC) (Caltag, South San Francisco, CA). The cells were washed twice again and blocked with excess mouse IgG (100 g/ml) followed by staining with directly conjugated Abs against the relevant cell surface molecules. The Abs used for staining were PE, FITC, TC, or peridin chlorophyll protein conjugates of anti-human CCR5 and CXCR4; anti-mouse CD3, CD4, CD8, CD44, CD45RB, and ␥␦TCR (PharMingen, San Diego, CA); anti-human CD4 and CD45RO, and secondary Abs goat anti-mouse PE or FITC FIGURE 1. Bonzo Ab specifically stains transfected cells. a, HOS cells stably expressing Bonzo were generated by retroviral transduction of the Bonzo or CCR5 cDNA using the pBabe vector (20) . Cells were stained with the anti-Bonzo mAb followed by a PE-conjugated goat-anti-mouse Ab. b, 293T cells were transfected with a pcDNA3 plasmid encoding either GFP or Bonzo-GFP fusion protein. Cells were then stained, 48 h posttransfection, with Bonzo Ab as described above. To perform FACS analyses on fresh human thymocytes, thymi were obtained from 7-to 9-mo-old pediatric heart surgery cases. Thymic tissue was disrupted by mincing and forcing through stainless steel mesh. Thymocytes were incubated twice at 37°C for 30 min in complete medium to remove adherent cells. Single-cell suspensions were then placed on ice and stained for FACS analysis as described above.
Gene targeting in embryonic stem cells and generation of mice
A 129/Sv mouse genomic DNA library was screened with human Bonzo cDNA and a 16-kb DNA fragment was isolated. Sequence analysis identified a 1.2-kb intronless open reading frame (ORF) homologous to that of the human Bonzo gene. To generate an EGFP (Clontech) knockin targeting vector, three DNA fragments were sequentially inserted into a pBS-KS ϩ plasmid: 1) a GFP expressing cassette followed by SV40 poly(A)n sequence, 2) a neomycin resistance cassette (neo R ) flanked with loxP sites (28) , and 3) a HSV thymidine kinase cassette (HSV-TK). Subsequently, an 8-kb ApaI-NotI genomic fragment downstream of the Bonzo ORF was inserted between the neo R and HSV-TK cassettes, whereas a 1.6-kb genomic fragment upstream of the Bonzo ORF and containing the 5Ј-untranslated region was inserted 5Ј of the GFP ORF. The resulting targeting vector was linearized with ClaI and electroporated into 129/Sv-derived E14 embryonic stem (ES) cells. G418-resistant ES cell clones were then screened for homologous recombination. To eliminate possible interference from the neo gene, correctly targeted clones were electroporated with a Cre recombinase-expressing vector (pCMV-Cre) to delete the neo R cassette, which was confirmed by sensitivity to G418 and by PCR or Southern blotting for the absence of the neo R -coding region. The resulting clones were microinjected into C57BL/6 blastocysts. Chimeric mice were mated with wild-type C57BL/6 mice to produce heterozygous progeny. Six-to 8-wk-old littermates from the mating of heterozygous mice were then analyzed.
RT-PCR analysis
Total RNA was extracted from mouse lymph nodes and spleen using Trizol reagent (Life Technologies). The RNA was further treated with RNase-free DNase I (Roche, Indianapolis, IN). RNA (1 g) was used in an Access RT-PCR system (Promega, Madison, WI) with 50 pmol of sense (GCT TGC TCA TTT GGG TG) and antisense (CGC CGC GTC GAC CTT CTC TAA GTG TGG CAA GGC) Bonzo primers. RT was performed for 45 min at 48°C, and cDNA amplification was conducted for 40 cycles at 94°C for 30 s, 58°C for 1 min, and 68°C for 2 min. To exclude possible contamination with genomic DNA, control reactions in which reverse transcriptase was omitted were performed in parallel.
Fluorescence microscopy
Mouse organs were fixed in 4% formaldehyde for at least 12 h and incubated in 15% sucrose in PBS for 1 h. The samples were embedded in HistoPrep (Fisher, Fairlawn, NJ) and later frozen with dry ice. Samples were cut into 15-m sections with a cryostat. Fluorescence microscopy was used to visualize GFP expression.
Results
Bonzo expression pattern on PBMC
An mAb reacting against human Bonzo was obtained as described in Materials and Methods. This Ab binds specifically to HOS cells that stably express the Bonzo cDNA (Fig. 1a) (20) . Similar results were obtained using Bonzo-transduced NIH-3T3 cells or a mouse thymoma line (data not shown). In addition, 293T cells were transfected with a plasmid encoding Bonzo-GFP fusion and stained with anti-Bonzo Ab. Only Bonzo-GFP-expressing cells were positively stained with anti-Bonzo mAb, and this correlated with GFP expression. To exclude the cross-reactivity of the Ab with other chemokine receptors, we also stained HOS cell lines stably expressing CCR1, CCR3, CCR4, CCR7, CCR8, APJ, and V28. None of these cell lines was stained with anti-Bonzo mAb (data not shown). We then determined the expression pattern of Bonzo on PBMC of normal donors using multicolor FACS analysis. Expression of Bonzo was found to segregate primarily to CD3 ϩ T cells (Fig. 2a) . Both CD4 ϩ and CD8 ϩ T cell subsets expressed Bonzo (Fig. 2, b and c) , although the percentage of Bonzo ϩ cells was always higher within the CD8 ϩ subset in samples obtained from different donors (data not shown). T cells can also be subdivided into memory and naive subsets based on expression of CD45 isoforms, CD45RO ϩ RA Ϫ and CD45RO Ϫ RA ϩ , respectively (29) . Bonzo was exclusively expressed on CD45RO ϩ T cells (Fig. 2d) . About 30 -40% of ␥␦ T cells also expressed Bonzo (Fig. 2f) . The few CD3-negative cells that expressed Bonzo were CD16 ϩ NK cells (Fig. 2e) , and no expression was detected on B cells, monocytes, or dendritic cells (Fig. 2, g, h, and i, respectively) .
It has been reported that expression of some chemokine receptors, such as the major HIV coreceptor CCR5, is also restricted to the memory subset of T cells (30) . As shown in Fig. 3 , the expression profile of CCR5 on resting T cells very closely parallels that of Bonzo. Indeed, costaining of PBMC with Abs specific for Bonzo and CCR5 showed that most Bonzo-positive cells were also CCR5 ϩ (Fig. 4) . PBMC from a healthy donor with a mutation in the CCR5 gene that prevents its cell surface expression (31) exhibited normal expression of Bonzo (Fig. 3b) , demonstrating that absence of CCR5 from the cell surface does not negatively influence Bonzo expression. Most Bonzo-positive resting T cells also expressed CCR6 (Fig. 4) , whereas expression of Bonzo and CXCR4 was inversely correlated (Fig. 4) . This inverse expression pattern reflects lower levels of CXCR4 on memory T cells (30) (data not shown), which preferentially express Bonzo (Fig. 2d) .
We also analyzed the expression of Bonzo within the thymus and secondary lymphoid organs, adenoids and tonsils. Bonzo, CCR5, and CCR6 expression was either undetectable or was present on Ͻ1% of thymocytes, whereas the majority of the thymocytes expressed CXCR4 (data not shown). Expression profiles of Bonzo, CCR5, and CCR6 on the lymphocytes isolated from tonsils or adenoids were similar to those observed on PBMC, although a greater proportion of T cells was positive, and most of these cells expressed CD45RO
ϩ as well as the early activation marker CD69 (data not shown).
Regulation of Bonzo expression by cytokine stimulation of resting T cells
The concordant subset distribution of Bonzo and CCR5 suggested that the surface expression of these molecules may be regulated by similar mechanisms. It has been noted that IL-2 or IL-15 stimulation of human T cells can up-regulate some of the CC chemokine ϩ and CD8 ϩ T cells. Purified CD4
ϩ or CD8 ϩ resting T cells were cultured for 8 days in the presence of the cytokines IL-2 (200 U/ml), IL-4 (20 ng/ml), IL-7 (10 ng/ml), and IL-15 (10 ng/ml). Cells were then stained with mAbs specific for Bonzo and for CD45RO and CD4 or CD8 (top and lower panels, respectively).
FIGURE 6.
Cytokine-mediated coregulation of Bonzo and chemokine receptors CCR5, CCR6, or CXCR4 on resting T cells. Purified CD4 ϩ T cells were cultured with cytokines as described in Fig. 5 . Cells were stained for Bonzo, CCR5, CCR6, or CXCR4 expression as described in Fig. 4. receptors (27, (32) (33) (34) . We asked whether Bonzo is similarly regulated by cytokines on resting human T cells. CD4 ϩ and CD8 ϩ resting T cells were purified from PBMC and cultured for 8 days in the presence of various cytokines. Culture of CD4 ϩ or CD8 ϩ T cells with IL-2 or IL-15 resulted in up-regulated expression of Bonzo exclusively on CD45RO ϩ memory T cells (Fig. 5) , with expression on CD8 ϩ T cells usually greater than that on CD4 ϩ T cells. This result is consistent with the staining pattern observed on freshly isolated PBMC. Little expression was observed on CD4 ϩ T cells cultured with IL-4 or IL-7 (Fig. 5) , and none was found with IL-6, IL-12, or IFN-␥ (data not shown). However, significant up-regulation of Bonzo was observed on CD8 ϩ T cells cultured with IL-7 (Fig. 5, lower panel) . IL-2 and IL-15 also up-regulated CCR5 and CCR6 expression on CD4 ϩ T cells, and most Bonzoexpressing cells also coexpressed these CC chemokine receptors (Fig. 6) . Similar results were obtained with CD8 ϩ T cells (data not shown). This result recapitulates the coordinate expression profile of Bonzo with CCR5 or CCR6 in freshly isolated PBMC (Fig. 4) . Conversely, Bonzo-positive cells had slightly lower CXCR4 expression than Bonzo-negative cells after stimulation with IL-2 or IL-15 (Fig. 6 ). CXCR4 expression was significantly up-regulated in the presence of IL-4, and there was also a moderate increase in response to IL-2 or IL-15, in accordance with previous reports (35) (36) (37) .
Post-transcriptional regulation of Bonzo cell surface expression
Most chemokine receptors contain a DRY sequence motif that appears to be required for coupling to G proteins (38) . In contrast to other CC and CXC-family chemokine receptors, Bonzo possesses a noncanonic DRY box sequence at the second intracellular loop. This raised the possibility that in response to its physiologic ligand Bonzo may not signal in a similar fashion to the other chemokine receptors. Recently, it has been reported that chemokine receptors are down-regulated through ligand-mediated endocytosis (39 -42) . Therefore, we reasoned that if any of the CCR5 ligands also bound to Bonzo, we may be able to detect this through down-regulation of Bonzo in the absence of detectable signaling. Fig. 7a shows that none of the known CCR5 ligands (MIP-1␣, MIP-1␤, and RANTES) had any effect on Bonzo expression, whereas they completely down-modulated CCR5 at the same concentrations. As expected, CXCR4 was down-modulated by its ligand SDF-1␣, but not by CCR5 ligands (Fig. 7a) . Interestingly, stimulation of cells with phorbol ester (PMA) also did not have any effect on Bonzo expression, although CCR5 and CXCR4 expression was completely down-modulated (Fig. 7b) . Similarly, upon restimulation of T cell lines with mitogen, CCR5 expression was down-modulated, but that of Bonzo was unaffected (Fig. 7c) . To determine whether Bonzo is premade, stored in intracellular compartments, and released to cell surface upon signaling, we performed intracellular staining on resting or cytokine-stimulated primary T cells with anti-Bonzo Ab. No difference was observed between cell surface staining alone or in conjunction with intracellular staining (data not shown).
Targeted disruption and knockin of EGFP into the mouse Bonzo gene locus
To gain insight into the expression pattern and function of Bonzo in mice, we used a gene-targeting strategy that replaced the Bonzocoding sequence with that of EGFP (Fig. 8A ) Germline transmission was obtained with two independent ES cell clones. Deletion of the Bonzo gene was verified by Southern blot analysis (Fig. 8B) . In an RT-PCR assay, a 3Ј portion of Bonzo mRNA was amplified from total RNA derived from lymph node and spleen of both 
Tracing mouse Bonzo expression in EGFP knockin mice
The in-frame substitution of EGFP for Bonzo yields a sensitive tool to trace Bonzo expression and regulation in vivo. Histologic analysis did not show any GFP expression in nonlymphoid tissues. Strong green fluorescence was detected in spleen and lymphoid nodes. In spleen, GFP-positive cells were clustered in the periarteriolar lymphoid sheath area in the white pulp, where T cells reside (Fig. 9) . Notably, there was no difference in expression pattern between Bz ϩ/Ϫ and Bz Ϫ/Ϫ mice. We next performed FACS analysis of GFP expression in different lymphoid subsets. GFP expression was undetectable in B cells, granulocytes, monocytes or macrophage, and dendritic cells (data not shown). In thymus, no expression was observed in CD4 ϩ CD8 ϩ cells or double-negative thymocytes. Only a small subset of single-positive cells showed strong expression (data not shown).
Within the lymph nodes and spleen almost all GFP ϩ cells were CD3 ϩ T cells (Fig. 10a) . The mean fluorescence of GFP-expressing Bz Ϫ/Ϫ cells was slightly higher than that of Bz ϩ/Ϫ cells, most likely due to GFP expression from both targeted alleles (data not shown). Few CD4 ϩ T cells expressed GFP, whereas the majority of CD8 ϩ T cells were positive, with a broad distribution of intensity of GFP expression. We next analyzed the distribution of GFP expression on naive vs memory T cells in Bonzo knockin mice. CD8 ϩ cells were all CD44 ϩ , and it was difficult to discriminate naive vs memory cells (Fig. 10b) . ␥␦ T cells from lymphoid organs or resident within the skin, reproductive tract, or gut also expressed GFP (Fig. 10c) . Interestingly, GFP expression on CD4 ϩ murine T cells was restricted to the CD44 ϩ and CD45RB low subset (Fig.   10d ), suggesting that, as in human CD4 ϩ T cells, Bonzo is primarily expressed in the memory subset of mouse CD4 ϩ T cells. Finally we determined whether, similar to human Bonzo, expression of mouse Bonzo can be modulated by the presence of cytokines. Indeed, we observed dramatic up-regulation of GFP expression after 10 days of culture with IL-2, but less with IL-7 and none with IL-4. These results suggest that cytokine-mediated regulation of murine Bonzo follows the pattern of its human counterpart (Fig. 11) .
Discussion
The discovery that HIV and SIV use chemokine receptors to enter target cells raised hopes that chemokines and chemokine receptors might hold clues to understanding the progression of HIV-mediated pathogenesis. These discoveries also bolstered the general interest in the regulation of lymphocyte migration by chemokine receptors. The recent development of Abs to chemokine receptors has revealed the complex subset-specific expression of these receptors on T lymphocytes (43) . In this report we demonstrate that the expression pattern and regulation of the SIV/HIV coreceptor and putative orphan chemokine receptor Bonzo strongly parallels those of CC family chemokine receptors.
It has been shown that CC family chemokine receptors CCR2, CCR5, and CCR6 are expressed primarily on the CD45RO ϩ or CD26 ϩ memory subset of T cells (30, 44 -46) . The expression pattern of Bonzo was similarly restricted to memory T cells. In this regard we found that most Bonzo-positive cells also coexpressed CCR5 or CCR6 on peripheral blood T cells. In contrast, Bonzo was not coexpressed with high levels of CXCR4, reflecting lower CXCR4 expression on memory vs naive T cells (30) . Although Bonzo was expressed on CD4 ϩ , CD8 ϩ and ␥␦ subsets of T cells, expression levels were usually higher on CD8 ϩ and TCR␥␦ ϩ T cells. Few NK cells were found to express Bonzo, and those that did had relatively low levels of CD16 expression (Fig. 2e) , possibly representing recently activated NK cells.
The coexpression of Bonzo and CCR5 on memory T cells is notable from the perspective of HIV coreceptor usage, because CCR5 is the major receptor used by most strains of HIV and almost all SIVs. Expression of CCR5 on the cell surface has been shown to be critical in transmission of HIV-1 infection, because a homozygous 32-bp deletion in the CCR5 gene prevents CCR5 expression and confers resistance against HIV-1 infection (31, 47, 48) . We showed that T cells isolated from individuals who are homozygous for the CCR5⌬32 mutation expressed normal levels of Bonzo. Although Bonzo is a minor HIV-1 coreceptor, its role during transmission of infection and pathogenesis is unclear. However, Bonzo is a major SIV receptor and is also used by many HIV-2 strains in vitro (18, 20) . It is interesting to note that different species of nonhuman primates vary widely in their responses to SIV infection, and people infected with HIV-2 usually have a more delayed progression to AIDS. It is possible that Bonzo may substitute for CCR5 usage during infection with SIV and HIV-2 isolates and perhaps influences the course of infection and pathogenesis. In contrast to CCR5, Bonzo was not expressed by macrophages or dendritic cells. This expression pattern may preclude its involvement during the initial phase of infection, where macrophage or dendritic cell infection is thought to be necessary for the virus to gain a foothold in the body (49) .
Cytokine stimulation of T cells differentially regulates the surface expression of chemokine receptors. IL-2 has been described to potently up-regulate CCR1, CCR2, CCR5, CCR6, and CXCR3 (27, 30, 32, 50, 51) . More recently, IL-15 has been shown to have similar effects on some of the CC chemokine receptors (27, 33) . In contrast, CXCR4 expression is dramatically up-regulated in the presence of IL-4 (35) (36) (37) . We have shown that Bonzo, similar to CC chemokine receptors, is induced through stimulation of highly purified resting T cells with IL-2 or IL-15 and is coexpressed with CCR5 or CCR6. The coordinated regulation of Bonzo and CCR5 on resting T cells by IL-2 or IL-15 recapitulates the ex vivo expression pattern. Notably, the gene for Bonzo maps to chromosome 3, where most of the chemokine receptors, especially those of the CC family, are localized (21) . Additionally, the amino acid sequence of Bonzo is similar to that of other members of the chemokine receptor family. Taken together with our results on its expression pattern and cytokine-mediated regulation, these findings suggest that Bonzo is also a chemokine receptor. However, Bonzo stands apart from other chemokine receptors, because its expression is resistant to PMA-induced down-modulation. This result contrasts with PMA-induced down-modulation of CXCR4 (52, 53) , CCR5 (Fig. 7b) , or CCR6 (data not shown). However, Bonzo may still be down-modulated by its ligand(s), because the mechanisms of ligand-and PMA-induced down-modulation appear to be different (42, 52, 53) . We did not detect any ligand-induced down-modulation of Bonzo in the presence of CCR5 ligands, but we cannot rule out that Bonzo is resistant to ligand-induced endocytosis and thus may still be able to bind to these chemokines.
Because there is no Ab yet available against mouse Bonzo, we used the targeted knockin of GFP in place of the Bonzo gene as an indicator of Bonzo expression. We found that murine Bonzo is expressed in cell subsets similar to human Bonzo, namely in T cells, particularly those displaying markers of effector/memory cells and those stimulated by IL-2 (data not shown). However, in both mouse and human only a subset of memory cells expressed Bonzo, similar to CCR5 expression. Chemokines regulate both the inter-and intraorgan migration patterns of human T cell subsets. Recently, human memory T cells were subdivided into two functionally distinct subsets based on CCR7 expression (54) . CCR7 Ϫ memory cells express receptors for migration to inflamed tissues and display immediate effector function. In contrast, CCR7 ϩ memory cells express lymph node-homing receptors and lack immediate effector function. Interestingly, the CCR7 Ϫ cells were enriched for expression of CCR5, CCR6, and CCR1 (54) . Based on the similar expression patterns, we would predict that the majority of Bonzo ϩ T cells will be compartmentalized to the CCR7 Ϫ memory subset, suggesting a role for Bonzo in recruiting memory T cells to sites of inflammation.
In homozygous Bonzo knockout mice we have not yet detected any functional defect. This may be due to redundancy in the chemokine receptor system. However, it will be important to perform more detailed analyses of migration patterns of T cells in response to a wide variety of pathogens and in particular to study T cell memory responses to the pathogens. Mutations in other chemokine receptor family members, such as CCR5 and CCR2, resulted in phenotypes revealed only after studies in responses to pathogen or in disease models (55) (56) (57) (58) . It will also be interesting to establish multiple knockouts between the Bonzo mutant mice and mutants for other chemokine receptors expressed in memory T cells to identify potentially overlapping functions of these molecules.
Bonzo is unique in that its sequence bears a noncanonic DRY box motif that is thought to couple chemokine receptors to G proteins (18, 20) . It is currently not known whether Bonzo elicits signals that are similar to those of other chemokine receptors. It will be critical to identify the natural ligand(s) of Bonzo to understand the receptor's signaling function. In addition, mice in which the Bonzo gene has been replaced with EGFP may be of considerable utility for tracking the migration patterns of memory T cell in responses to inflammatory stimuli. New insight into the expression pattern and function of Bonzo may also help elucidate its role during SIV/HIV infection.
